Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection

dc.contributor.authorMarrero-Hernández, Sara
dc.contributor.authorMárquez-Arce, Daniel
dc.contributor.authorCabrera-Rodríguez, Romina
dc.contributor.authorEstévez-Herrera, Judith
dc.contributor.authorPérez-Yanes, Silvia
dc.contributor.authorBarroso-González, Jonathan
dc.contributor.authorMadrid, Ricardo
dc.contributor.authorMachado, José David
dc.contributor.authorBlanco, Julia
dc.contributor.authorValenzuela-Fernández, Agustín
dc.date.accessioned2023-06-16T15:19:56Z
dc.date.available2023-06-16T15:19:56Z
dc.date.issued2019-10-30
dc.description.abstractHIV Nef is a central auxiliary protein in HIV infection and pathogenesis. Our results indicate that HDAC6 promotes the aggresome/autophagic degradation of the viral polyprotein Pr55Gag to inhibit HIV-1 production. Nef counteracts this antiviral activity of HDAC6 by inducing its degradation and subsequently stabilizing Pr55Gag and Vif viral proteins. Nef appears to neutralize HDAC6 by an acidic/endosomal-lysosomal processing and does not need the downregulation function, since data obtained with the non-associated cell-surface Nef-G2A mutant – the cytoplasmic location of HDAC6 – together with studies with chemical inhibitors and other Nef mutants, point to this direction. Hence, the polyproline rich region P72xxP75 (69–77 aa) and the di-Leucin motif in the Nef-ExxxLL160-165 sequence of Nef, appear to be responsible for HDAC6 clearance and, therefore, required for this novel Nef proviral function. Nef and Nef-G2A co-immunoprecipitate with HDAC6, whereas the Nef-PPAA mutant showed a reduced interaction with the anti-HIV-1 enzyme. Thus, the P72xxP75 motif appears to be responsible, directly or indirectly, for the interaction of Nef with HDAC6. Remarkably, by neutralizing HDAC6, Nef assures Pr55Gag location and aggregation at plasma membrane, as observed by TIRFM, promotes viral egress, and enhances the infectivity of viral particles. Consequently, our results suggest that HDAC6 acts as an anti-HIV-1 restriction factor, limiting viral production and infection by targeting Pr55Gag and Vif. This function is counteracted by functional HIV-1 Nef, in order to assure viral production and infection capacities. The interplay between HIV-1 Nef and cellular HDAC6 may determine viral infection and pathogenesis, representing both molecules as key targets to battling HIV.
dc.description.abstractJulià Blanco5,6 and Agustín Valenzuela-Fernández1
dc.description.departmentDepto. de Genética, Fisiología y Microbiología
dc.description.facultyFac. de Ciencias Biológicas
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Economía y Competitividad (MINECO)/FEDER
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades (MICINN)/FEDER
dc.description.sponsorshipFundación CajaCanarias/FEDER
dc.description.sponsorshipRed Española de Investigación del SIDA (RES-RETIC)/ISCII/FEDER
dc.description.sponsorshipAgencia Canaria de Investigación, Innovación y Sociedad de la Información/Fundación CajaCanarias/FEDER
dc.description.sponsorshipFundación Canaria Dr. Manuel Morales
dc.description.sponsorshipCabildo Tenerife
dc.description.sponsorshipFondo de Investigaciones Sanitarias (FIS)/ Instituto de Salud Carlos III (ISCIII)
dc.description.sponsorshipFundació Institut de Recerca en Ciències de la Salut Germans Trias i Pujol
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/61411
dc.identifier.doi10.3389/fmicb.2019.02437
dc.identifier.issn1664-302X
dc.identifier.officialurlhttps://www.frontiersin.org/articles/10.3389/fmicb.2019.02437/full
dc.identifier.urihttps://hdl.handle.net/20.500.14352/6379
dc.issue.number2437
dc.journal.titleFrontiers in Microbiology
dc.language.isoeng
dc.page.final24
dc.page.initial1
dc.publisherFrontiers Media
dc.relation.projectID(SAF2015-64118-R)
dc.relation.projectID(RTI2018-093747-B-I00); (SNEO-20161199)
dc.relation.projectIDBIO29 (UNLL10-3E-783)
dc.relation.projectID(RD16/0025/0011), (RD12/0017/0034), (RD12/0017/0002)
dc.relation.projectID(TESIS2015- 010038), (TESIS2017010116)
dc.relation.projectIDPrograma “Agustin de Betancourt” 2017
dc.relation.projectID(PI14/01307)
dc.rightsAtribución 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/es/
dc.subject.cdu578
dc.subject.cdu579
dc.subject.keywordHIV-1
dc.subject.keywordNef
dc.subject.keywordHDAC6
dc.subject.keywordPr55Gag
dc.subject.keywordacidic-endocytic/lysosomal degradation
dc.subject.keywordautophagy
dc.subject.keywordinfection
dc.subject.keywordviral production
dc.subject.ucmEnfermedades infecciosas
dc.subject.ucmMicrobiología (Biología)
dc.subject.unesco3205.05 Enfermedades Infecciosas
dc.subject.unesco2414 Microbiología
dc.titleHIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection
dc.typejournal article
dc.volume.number10
dspace.entity.typePublication

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Madrid-DGFM-HIV-1-Nef Targets.pdf
Size:
3.84 MB
Format:
Adobe Portable Document Format

Collections